Fluicell publishes 2022 Q4 Year-end report
Today, February 24 2023, Fluicell publishes the Q4 Year-end report for the period January to December, 2022. The…
Today, February 24 2023, Fluicell publishes the Q4 Year-end report for the period January to December, 2022. The…
Spheroids are a powerful tool for in vitro tissue and disease modeling, with multiple applications across cancer and…
Do you want to be part of an innovative team pushing the boundaries in 3D bioprinting, engineered tissue-based…
2022 has been a busy year for us at Fluicell. Not only have we this year released Biopixlar…
Today, November 30 2022, Fluicell publishes the interim report for the period July 1 to September 30, 2022….
Biopixlar AER is nominated as Innovation of the Year for the 2022 3D Printing Industry Awards! We at…
Erlab-Noroit has just completed a successful installation of a customized version of their H.Box Class II biosafety cabinet,…
We are happy to announce that we are attending the 4th Australian Bioprinting Workshop, taking place at Univserity…
Fluicell welcomes Sanna Sämfors who joins Fluicell as Application Specialist. In her role, Sanna will be developing bioprinting…